Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

Trichoscopy is useful for quickly diagnosing different types of hair loss without needing biopsies.

Younger people and those with existing acne are more likely to get folliculitis after hair restoration surgery, but it doesn't affect the overall good hair growth result.

Dr. Bernard Cohen created a new system to classify hair loss using numbers and a detailed scalp map.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Androgenetic alopecia may increase the severity of COVID-19.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Understanding hair follicles through various models can help develop new treatments for hair disorders.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.

Hair thinning causes stem cell loss through a process involving Piezo1, calcium, and TNF-α.

Scaffold-based strategies show promise for regenerating hair follicles and teeth but need more research for clinical use.

Trichoscopy can diagnose monilethrix, a genetic hair defect causing hair thinning and loss.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Men with early-onset hair loss have more heart disease risk factors.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Botulinum toxin injections can help treat common hair loss in men, but more research is needed to confirm this and understand how it works.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Robotic hair transplants are easier and quicker to learn than traditional methods.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

Lentiginous melanoma is most common on the face, especially the nose, cheek, and pre-auricular areas, with men more likely to have it on the scalp, ears, upper back, and trapezius, and women on the cheek and anterior arm. Sun damage is a key factor in its formation.

The method is effective for evaluating hair loss treatments quickly and affordably.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.